Vimarsana
Biggest News Aggregation in the World

Emmessar Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emmessar Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emmessar Biotech Today - Breaking & Trending Today

Stocks plunged news: Sensex rises! But these stocks are down 5% or more on BSE - Vimarsana News

Stocks plunged news: Sensex rises! But these stocks are down 5% or more on BSE

In the Nifty pack, 25 stocks were trading in the green, while 25 stocks were trading in the red.

Stocks plunged news: Sensex falls! These stocks fell 5% or more in Friday's session - Vimarsana News

Stocks plunged news: Sensex falls! These stocks fell 5% or more in Friday's session

In the Nifty pack, 24 stocks closed in the green, while 26 stocks ended in the red.

Emmessar Biotech & Nutrition Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 - Vimarsana News

Emmessar Biotech & Nutrition Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023

Emmessar Biotech & Nutrition Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 3.28 million...

Emmessar Biotech & Nutrition Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 - Vimarsana News

Emmessar Biotech & Nutrition Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023

Emmessar Biotech & Nutrition Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 0.843 million...

Sign of confidence! Promoters just increased their stake in these companies - Vimarsana News

Sign of confidence! Promoters just increased their stake in these companies

The promoters of Camlin Fine Sciences raised their stake in the company by 31.51 percentage points to 48.03 per cent in Q2